Advertisement

Topics

Pierre Guerin Company Profile

22:20 EDT 19th September 2017 | BioPortfolio

BIOLAFITTE Aseptic Processes Expertise support the Health Industries focused on the Biotech, Pharmaceutical and Cosmetics markets.

Our areas of competence include :

- Fermenter / Bioreactor process design and manufacturing of complete systems.

- Project management

- Process engineering (P&ID, functional analysis)

- Mechanical design (vessels and piping - 3D isometric drawings)

- Electrical and control system design, programming

- Piping manufacturing and wiring

- Commissioning and after-sales services

- Qualification support (cGMP,GAMP,CFR21 part11)



These technical skills combined with our in house process vessel manufacturing, after-sales service, and distribution network allow us to provide a full range of products and services that meets the needs of our worldwide customer base.

Location

179, Grand'Rue BP 12
79210 MAUZE-SUR-LE-MIGNON
MAUZE
France

Contact

Phone: + 33 (0)5 49 04 78 00
Email: contact@pierreguerin.fr


News Articles [54 Associated News Articles listed on BioPortfolio]

Pierre Fabre to commercialize Aprotecol in Italy

Spain-based Noventure and the Italian subsidiary of France’s Pierre Fabre have entered into an agreement…

Jean-Pierre van Besouw

bmj;358/sep07_10/j4103/FAF1faJean-Pierre van Besouw, who has died at the age of 60 nearly two years after being diagnosed with a brain tumour, championed the perioperative role of anaesthetists.... ...

Pierre Fabre sets sights on bigger I-O business

Privately-held Pierre Fabre Pharmaceuticals is buying immuno-oncological candidates from Igenica Biotherapeutics,…

Pierre Fabre Acquires Ingenica Immuno-Oncology Assets

Pierre Fabre said today it has agreed to acquire “several” cancer immunotherapies from Igenica Biotherapeutics for an undisclosed price, in a deal designed to strengthen the buyer’s oncology pip...

Pierre Fabre Acquires Igenica Immuno-Oncology Assets

Pierre Fabre said today it has agreed to acquire “several” cancer immunotherapies from Igenica Biotherapeutics for an undisclosed price, in a deal designed to strengthen the buyer’s oncology pip...

Pierre Fabre Buys Igenica Immuno-oncology Assets

Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area

Pierre Fabre secures Italian distribution rights for Noventure's Aprotecol

Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s paediatric intestinal treatment Aprotecol in Italy. read more

Pierre Fabre to buy Igenica Biotherapeutics’ assets for treating cancer patients

French private pharmaceutical group Pierre Fabre has signed a new definitive purchase agreement to acquire several assets from US biotechnology company Igenica Biotherapeutics.

PubMed Articles [37 Associated PubMed Articles listed on BioPortfolio]

Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics.

To assess the influence of the treatment with 5-azacytidine (5-aza) on the profile of metal-containing proteins and factors of their regulation in Guerin carcinoma cells in vivo.

Ameloblastic Fibro-Odontoma of the Maxilla in a Pierre-Robin Sequence Patient.

Pierre Robin sequence (PRS) is a rare disorder classically observed as a triad of features including micrognathia, glossoptosis, and upper airway obstruction. It is associated with a syndrome in about...

Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.

This study aimed to evaluate the immunogenicity and protective efficacy of recombinant bacille calmette-guerin (rBCG) strains expressing Ag85A (A), CFP10 (C), ESAT6 (E), IL-12p70 (I), and fusion prote...

Haplotype of the Interleukin 17A gene is associated with osteitis after Bacillus Calmette-Guerin vaccination.

Bacillus Calmette-Guerin (BCG) osteitis was more common in Finland than elsewhere at the time when universal BCG vaccinations were given to Finnish newborns. There is evidence that IL-17 plays a role ...

TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment.

In the past decade, interest in the century-old tuberculosis vaccine, bacillus Calmette-Guerin (BCG), has been revived for potential new therapeutic uses in type 1 diabetes and other forms of autoimmu...

Clinical Trials [38 Associated Clinical Trials listed on BioPortfolio]

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

The purpose of this study is to determine if treatment with the autologous cellular vaccine, Melaxin, in combination with Bacillus Calmette-Guerin (BCG) injections is effective in Stage I...

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

The purpose of this study is to compare the bladder cancer treatments, Mitomycin C (MMC) and Bacillus Calmette Guerin (BCG), to find out which is better. In this study, the patient will ge...

Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine

BCG has marked immune stimulatory effects in both animal and human studies and observational studies suggest that BCG is associated with a non-specific reduction in mortality in areas with...

Companies [29 Associated Companies listed on BioPortfolio]

PIERRE GUERIN S.A.S

Supporting Food and Health industriesA specialist in stainless steel products and a designer and manufacturer of process vessels integrating sophisticated and innovative features in agitation, mixing,...

PIERRE GUERIN TECHNOLOGIES

1949Pierre Guérin creates his company in Mauzé sur le Mignon in Southwestern France, developed from a family business in dairy farm equipment and maintenance. Supporting the Food and Health industri...

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Pierre Guerin

BIOLAFITTE Aseptic Processes Expertise support the Health Industries focused on the Biotech, Pharmaceutical and Cosmetics markets.Our areas of competence include :- Fermenter / Bioreactor process desi...

More Information about "Pierre Guerin" on BioPortfolio

We have published hundreds of Pierre Guerin news stories on BioPortfolio along with dozens of Pierre Guerin Clinical Trials and PubMed Articles about Pierre Guerin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pierre Guerin Companies in our database. You can also find out about relevant Pierre Guerin Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record